“

In between pandemic times, we must learn lessons about improving infrastructure for research across low and lower-middle income settings, we need several large hubs, manufacturing sites across Africa and Southeast Asia and South America that are able to develop at large scale vaccines and diagnostics and therapeutics, and with the paperwork in place as well.